P2.03b-016 Tesevatinib in NSCLC Patients with EGFR Activating Mutations and Brain Metastases (BM) or Leptomeningeal Metastases (LM): Topic: Brain Meta Davic Berz, Deepa Subrananiam,James Tonra,Mark Berger,D. Ross CamidgeJournal of Thoracic Oncology（2017）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
